![The F-35’s future: Can the fifth-gen fighter withstand political, technological headwinds? [Video]](https://breakingdefense.com/wp-content/uploads/sites/3/2024/04/240401_f35_clouds_8270083-scaled-e1711999276822.jpg?#)
Human medicines European public assessment report (EPAR): Ibrance, palbociclib, Date of authorisation: 09/11/2016, Revision: 24, Status: Authorised
Human medicines European public assessment report (EPAR): Ibrance, palbociclib, Date of authorisation: 09/11/2016, Revision: 24, Status: Authorised
Human medicines European public assessment report (EPAR): Ibrance, palbociclib, Date of authorisation: 09/11/2016, Revision: 24, Status: Authorised
